Vivos Therapeutics, Inc. (VVOS) NASDAQ

5.26

+0.195(+3.85%)

Updated at January 15 12:14PM

Currency In USD

Valuation

Market Cap15.17M
Enterprise Value15.52M
P/E Ratio-2.66
PEG Ratio-0.12
Price/Sales Ratio2.04
Price/Book Ratio4.37
Enterprise/Revenue1.72
Enterprise/EBITDA-2.09

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-0.86
Operating Margin-0.85

Management Effectiveness

Return On Assets-0.82
Return On Equity-3.35

Income Statement

Revenue13.8M
Revenue/Share2.2
Gross Profit8.27M
EBITDA-16.68M
Net Income-13.58M
Diluted EPS-11.14

Balance Sheet

Total Cash6.31M
Total Cash/Share0.95
Total Debt1.64M
Total Debt/Equity0.21
Current Ratio1.44
Book Value Per Share1.16

Price History

52-Week Change-29.33
52-Week High9.14
52-Week Low1.91
Moving Average 50 Days3.83
Moving Average 200 Days2.88

Statistics

Average Volume218,813
Shares Outstanding5.89M
% Held by Institutions0.33

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateOctober 27, 2023